Author

Davide Giugliano

Full Professor of Endocrinology and Metabolic Diseases at Universit

Biography

Davide Giugliano Multidisciplinary Department of Medical-Surgical and Dental Specialties, Second University of Naples, Naples, Italy. He published articles in a wide range of fields on like Endodontics, Orthodontics, Dental Implants, Prosthodontics, Restorative Dentistry, Oral and Maxillofacial Surgery, Periodontics, Forensic Dentistry, Digital Dentistry, Minimal Intervention Dentistry etc
Title
Cited by
Year
Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials
MI Maiorino, S Signoriello, A Maio, P Chiodini, G Bellastella, ...Diabetes Care 43 (5), 1146-1156, 2020202
168
2020
Diabetes and aging: from treatment goals to pharmacologic therapy
M Longo, G Bellastella, MI Maiorino, JJ Meier, K Esposito, D GiuglianoFrontiers in Endocrinology 10, 45, 2019201
134
2019
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome
MI Maiorino, G Bellastella, D Giugliano, K EspositoJournal of Endocrinological Investigation 41 (11), 1249-1258, 2018201
115
2018
GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: an updated meta‐analysis including the REWIND and PIONEER 6 trials
D Giugliano, MI Maiorino, G Bellastella, M Longo, P Chiodini, K EspositoDiabetes, Obesity and Metabolism 21 (11), 2576-2580, 2019201
115
2019
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
D Giugliano, L Scappaticcio, M Longo, P Caruso, MI Maiorino, ...Cardiovascular Diabetology 20 (1), 1-11, 2021202
97
2021
Glycemic control, preexisting cardiovascular disease, and risk of major cardiovascular events in patients with type 2 diabetes mellitus: systematic review with meta‐analysis of …
D Giugliano, MI Maiorino, G Bellastella, P Chiodini, K EspositoJournal of the American Heart Association 8 (12), e012356, 2019201
78
2019
Diabetic foot problems during the COVID-19 pandemic in a tertiary care center: the emergency among the emergencies
P Caruso, M Longo, S Signoriello, M Gicchino, MI Maiorino, G Bellastella, ...Diabetes care 43 (10), e123-e124, 2020202
76
2020
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes
D Giugliano, MI Maiorino, G Bellastella, K EspositoJournal of Endocrinological Investigation 42, 495-503, 2019201
66
2019
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
D Giugliano, M Longo, L Scappaticcio, G Bellastella, MI Maiorino, ...Cardiovascular Diabetology 20 (1), 1-11, 2021202
59
2021
Heart failure and type 2 diabetes: from cardiovascular outcome trials, with hope
D Giugliano, JJ Meier, K EspositoDiabetes, Obesity and Metabolism 21 (5), 1081-1087, 2019201
52
2019
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
M Longo, P Caruso, MI Maiorino, G Bellastella, D Giugliano, K EspositoCardiovascular Diabetology 19 (1), 1-5, 2020202
45
2020
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
D Giugliano, M Longo, S Signoriello, MI Maiorino, B Solerte, P Chiodini, ...Cardiovascular diabetology 21 (1), 42, 2022202
41
2022
Glucagon-like peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis
G Bellastella, MI Maiorino, M Longo, L Scappaticcio, P Chiodini, ...Stroke 51 (2), 666-669, 2020202
40
2020
Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
D Giugliano, M Longo, L Scappaticcio, P Caruso, K EspositoCardiovascular Diabetology 20, 1-10, 2021202
38
2021
Class effect for SGLT-2 inhibitors: a tale of 9 drugs
D Giugliano, K EspositoCardiovascular diabetology 18 (1), 1-4, 2019201
38
2019
Efficacy of SGLT-2 inhibitors in older adults with diabetes: systematic review with meta-analysis of cardiovascular outcome trials
D Giugliano, M Longo, MI Maiorino, G Bellastella, P Chiodini, SB Solerte, ...Diabetes Research and Clinical Practice 162, 108114, 2020202
34
2020
Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysis
D Giugliano, P Chiodini, MI Maiorino, G Bellastella, K EspositoJournal of endocrinological investigation 42, 1165-1169, 2019201
34
2019
S odium‐glucose co‐transporter‐2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis
D Giugliano, M Longo, P Caruso, MI Maiorino, G Bellastella, K EspositoDiabetes, Obesity and Metabolism 23 (7), 1672-1676, 2021202
34
2021
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study
FC Sasso, PC Pafundi, A Gelso, V Bono, C Costagliola, R Marfella, ...Nutrition, Metabolism and Cardiovascular Diseases 29 (9), 923-930, 2019201
33
2019
Type 2 diabetes and the kidney: insights from cardiovascular outcome trials
D Giugliano, L De Nicola, MI Maiorino, G Bellastella, K EspositoDiabetes, Obesity and Metabolism 21 (8), 1790-1800, 2019201
33
2019

Referred From: https://scholar.google.com/citations?hl=en&user=pNxVh_EAAAAJ

Cited by
Citations 57106
h-index 115
i10-index 421
Recommended Journals
Open Access Journals